Clenpiq Approval History
- FDA approved: Yes (First approved November 28th, 2017)
- Brand name: Clenpiq
- Generic name: sodium picosulfate, magnesium oxide, and anhydrous citric acid
- Dosage form: Oral Solution
- Company: Ferring Pharmaceuticals
- Treatment for: Bowel Preparation
Clenpiq (sodium picosulfate, magnesium oxide, and anhydrous citric acid) is a stimulant laxative and osmotic laxative combination indicated for cleansing of the colon as a preparation for colonoscopy.
Development History and FDA Approval Process for Clenpiq
|Nov 29, 2017||FDA Approves Clenpiq (sodium picosulfate, magnesium oxide, and anhydrous citric acid) Oral Solution for Colonoscopy Prep|
Disclaimer: Every effort has been made to ensure that the information provided here is accurate, up-to-date and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. This information has been compiled for use by healthcare practitioners and consumers in the United States. The absence of a warning for a given drug or combination thereof in no way should be construed to indicate that the drug or combination is safe, effective or appropriate for any given patient. If you have questions about the substances you are taking, check with your doctor, nurse or pharmacist.